Overview
A retinal implant that restores recognizable visual forms to blind patients anchors Max Hodak’s broader argument: the brain should be approached as a computer whose inputs, outputs, and internal representations can be engineered. Science’s Prima system places a photovoltaic chip beneath the retina and uses laser-projecting glasses to bypass damaged photoreceptors, enabling some clinical-trial participants to read books and complete puzzles. European marketing approval turns that result from a research demonstration into an emerging commercial product, although the current vision remains narrow, monochrome, and technically limited. Hodak contrasts this iterative engineering path with drug development, where years of molecular work may culminate in a binary clinical failure. His larger portfolio combines vision restoration, biohybrid neural interfaces, and organ-perfusion technology, reflecting the belief that preserving the brain matters more than preserving every biological support organ. The discussion then expands from medical devices into identity and consciousness: Hodak considers phenomenal continuity more important than creating a behaviorally accurate software copy. He also connects neuroscience with AI through the controversial Platonic Representation Hypothesis, citing alignments between neural recordings and model representations. Over the next two decades, he expects these technologies to reduce human fragility, enable replaceable or upgradeable bodily functions, and eventually support adaptation beyond Earth.
Sections
Core Concepts
Terms that define Hodak’s technological and philosophical framework.
- Brain-computer interface: A broad category encompassing technologies that record from, stimulate, restore, or extend neural functions—not merely systems that decode motor intent.
- Retinal prosthesis: An implanted device that substitutes for damaged light-sensitive retinal cells by directly stimulating surviving retinal circuitry.
- Form vision: A coherent perceived image, such as a face, shape, or paragraph, rather than disconnected flashes of light.
- Biohybrid neural interface: An interface based on grafted living neurons that integrate with the brain by growing and forming new biological connections.
- Platonic Representation Hypothesis: The proposition that learning systems converge on shared underlying representations or geometries because they capture the same structure in reality.
- Substrate independence: Preservation or continuation of a mind across replaceable, modifiable, or non-biological physical implementations.
Technology, Clinical State, and Commercial Scale
Specific architecture, performance, regulatory, and market details discussed in the interview.
- Prima uses a subretinal chip and laser-projecting glasses to convert external imagery into direct retinal stimulation, bypassing nonfunctional rods and cones.
- Potential neural entry points for artificial vision include the retina, the lateral geniculate nucleus in the thalamus, and primary visual cortex; Hodak favors the retina when the optic nerve remains functional.
- The current system provides a narrow, black-and-white field of view. Planned improvements include grayscale depth and potentially red and green color; blue is described as more difficult.
- Prima received European marketing approval in July after roughly two years of post-acquisition development, with initial commercial sales expected within weeks of the interview.
- An earlier retinal prosthesis from Second Sight reportedly received about $150,000 per patient in the mid-2010s, while a narrowly applicable gene therapy reimburses at nearly $500,000 per eye.
- The first Prima version is framed as serving hundreds of thousands of patients across the United States and Europe; a subsequent version entering animal studies could expand eligibility to millions.
- Hodak cites an approximately 10-bit-per-second cognitive bottleneck as a constraint on the value of high-bandwidth thought-to-AI communication.
Strategic and Scientific Implications
Higher-level conclusions implied by the company’s choices and Hodak’s arguments.
- Prima functions as more than a therapeutic product: it is a credibility bridge between commercially measurable medicine and far more speculative work on identity, consciousness, and substrate independence.
- Defining BCI around restored or altered capability rather than electrode location dissolves the boundary between neural engineering and several traditional medical specialties.
- Science’s strategy depends on replacing biological complexity with interfaces at points where signals are already compact and legible, such as sensory nerves, rather than reproducing every molecular mechanism.
- The shared-representation thesis creates a reciprocal research loop: AI models may help decode biological brains, while neural recordings provide evidence about whether AI has learned structures grounded in reality.
- If cognition is constrained by a low-bandwidth internal bottleneck and language helps construct thought, consumer BCIs may deliver less speed advantage than their marketing implies.
Forecasts
Future developments anticipated by Hodak, with uncertainty retained.
- Prima’s first commercial sales in Europe are expected to begin shortly after its July marketing approval.
- Science’s internally developed retinal gene therapy and the next Prima version may enter human studies.
- A complete mouse connectome may become available substantially sooner than a human connectome and could accelerate research into brain architecture and consciousness.
- Vision restoration, biohybrid interfaces, and perfusion medicine could collectively produce a significant medical transformation.
- Successful development of replaceable and upgradeable bodily functions could make people less vulnerable to cardiovascular disease, cancer, and organ failure.
- Long-term human space exploration will require adapting human substrates to hostile environments rather than reproducing Earth everywhere.